ALS Association — Research Funding Opportunities (General/Programs & Awards)
Who can apply: Each request for applications outlines the scope and eligibility.
TO DISCOVER TREATMENTS AND A CURE FOR ALS, AND TO SERVE, ADVOCATE FOR, AND EMPOWER PEOPLE AFFECTED BY ALS TO LIVE THEIR LIVES TO THE FULLEST.
Amyotrophic Lateral Sclerosis Association’s recent giving is defined by a liquidating distribution to The ALS Association in Arlington, Virginia, alongside a prior research grant to the same recipient. That combination points to a funder whose final grants sit at the intersection of ALS research and organizational transfer, rather than a broad, ongoing portfolio of many small awards. The foundation’s stated mission is to discover treatments and a cure for ALS and to serve, advocate for, and empower people affected by ALS to live their lives to the fullest. Its active programs show that mission in practice: support for preclinical therapy development, clinical trials, exploratory research, care centers, and patient and caregiver services. The result is a grantmaking profile centered on ALS science and the systems around it — from early-stage drug development to clinical infrastructure and support programs. One recent award was labeled for research, while the largest recent award was tied to a liquidating distribution, indicating that the foundation’s current profile is shaped by both programmatic support and a final asset distribution tied to dissolution.
The foundation funds several ALS-specific research lanes. Through the Lawrence and Isabel Barnett Drug Development Program, it supports preclinical research projects that advance promising ALS therapies toward clinical testing. Its Trial Capacity Awards are aimed at increasing participation and diversity in ALS clinical trials while improving speed and efficiency. The ALS Association Seed Grant Program backs exploratory ALS research projects, and the Prevention Grants Program focuses on efforts to prevent or delay ALS harms with the goal of affecting clinical care within 5–7 years. It also runs the ALS Roundtable Program, which convenes industry, academia, nonprofits, and funders to turn dialogue into action and catalyze collaborations.
Typical grant sizes are large: the 25th percentile is $1,584,902, the median is $1,666,550, and the 75th percentile is $1,748,197. The recent record shows two grants, both to The ALS Association in Arlington, Virginia, one in 2024 and one in 2023, which suggests a very concentrated distribution pattern rather than a wide spread of recipients. The foundation is classified as a regular funder and does not fund individuals or make program-related investments. Some of its active programs accept unsolicited applications, including the ALS Association research funding opportunities umbrella and the Seed Grant Program.
$1.8M
$0
$55K
$1.8M
Most grants fall between $1.6M and $1.7M, with a median of $1.7M.
25th Percentile
$1.6M
Median
$1.7M
75th Percentile
$1.7M
About 0% of grants go to recipients in VA.
RAY CARSON
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Grantmaking is regional and concentrated outside the headquarters state: 0% of grants in the recent dataset went to Florida, even though the foundation is headquartered in Tampa. The top state by grant count is Virginia, driven by both recent grants to Arlington. The recipient-country distribution is entirely U.S.-based in the data shown, with 2 grants in the United States and no non-U.S. recipients listed.
Its stated mission centers on ALS treatments, a cure, and support for people affected by ALS. Active programs cover preclinical drug development, clinical trial capacity, exploratory research, prevention research, care centers, patient support, and collaboration through the ALS Roundtable Program.
The grant-size distribution is high and tightly grouped: the 25th percentile is $1,584,902, the median is $1,666,550, and the 75th percentile is $1,748,197. The recent grants shown are both above $1.5 million.
Yes, for some research programs. The ALS Association Research Grants umbrella accepts unsolicited applications, and the ALS Association Seed Grant Program also accepts unsolicited applications. Other listed programs, such as Trial Capacity Awards and the Certified Center Program, do not.
Yes. The top state by grant count is Virginia, and the recent grants listed both went to Arlington, Virginia. In the dataset shown, 0% of grants went to Florida, where the foundation is headquartered.
The recent record shows grants to a single nonprofit recipient, The ALS Association, in two consecutive years. The foundation is also classified as a regular funder and does not fund individuals, which aligns with institutional grantmaking rather than personal awards.
2024
Source: IRS Form 990-PF, fiscal year 2024.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| THE ALS ASSOCIATION | ARLINGTON, VA | $1,829,845 | 2024 | LIQUIDATING DISTRIBUTION (SEE FORM 990, PART III, LINE 3 & SCHEDULE N) |
| THE ALS ASSOCIATION | ARLINGTON, VA | $1,503,254 | 2023 | RESEARCH |
THE ALS ASSOCIATION
$1,829,845LIQUIDATING DISTRIBUTION (SEE FORM 990, PART III, LINE 3 & SCHEDULE N)
THE ALS ASSOCIATION
$1,503,254RESEARCH
Current and upcoming funding from Amyotrophic Lateral Sclerosis Association that your nonprofit may be able to apply for.
Who can apply: Each request for applications outlines the scope and eligibility.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.